Purchases and Sales Made in Q4 2024 in Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS) during Q4 2024. The information is specifically focused on institutions that hold shares of Corvus Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 18, 2025
Q4 2024
|
Gf Fund Management Co. Ltd.
Guangzhou, F4 |
BUY
|
- |
1.35KNew |
$6.14K - $12.9K
|
1.35K
$5.81K
|
|
|
Feb 04, 2025
Q4 2024
|
Oppenheimer & CO Inc
New York, NY |
BUY
|
- |
1.1K+ 6.47% |
$4.99K - $10.5K
|
18K
$77.8K
|
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
1KNew |
$4.55K - $9.56K
|
1K
$4.31K
|
|
|
Feb 14, 2025
Q4 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
563+ 0.53% |
$2.56K - $5.38K
|
106K
$457K
|
|
|
Feb 11, 2025
Q4 2024
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
344+ 2.19% |
$1.57K - $3.29K
|
16K
$69.1K
|
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
290New |
$1.32K - $2.77K
|
290
$1.25K
|
|
|
Feb 10, 2025
Q4 2024
|
Signaturefd, LLC
Atlanta, GA |
BUY
|
- |
224New |
$1.02K - $2.14K
|
224
$965
|
|
|
Feb 12, 2025
Q4 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
169New |
$769 - $1.62K
|
169
$728
|
|
|
Feb 07, 2025
Q4 2024
|
Ever Source Wealth Advisors, LLC
|
BUY
|
- |
60New |
$273 - $574
|
60
$259
|
|
|
Feb 14, 2025
Q4 2024
|
Caitong International Asset Management Co., LTD
Hong Kong, K3 |
BUY
|
- |
20New |
$91 - $191
|
20
$86.2
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 04, 2025
Q4 2024
|
Ifp Advisors, Inc
|
SELL
|
- |
-24Closed |
$109 - $229
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-18.4K- 18.91% |
$83.5K - $176K
|
78.7K
$339K
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-25.1K- 50.65% |
$114K - $240K
|
24.5K
$105K
|
|
|
Feb 05, 2025
Q4 2024
|
Towerview LLC
|
SELL
|
- |
-40K- 34.04% |
$182K - $382K
|
77.5K
$334K
|
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-41.2K- 57.65% |
$188K - $394K
|
30.3K
$131K
|
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-43.4K- 70.8% |
$197K - $415K
|
17.9K
$77.1K
|
|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
SELL
|
- |
-74.6K- 60.75% |
$340K - $714K
|
48.2K
$208K
|
|
|
Feb 14, 2025
Q4 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-86K- 67.56% |
$391K - $822K
|
41.3K
$178K
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-156K- 50.24% |
$712K - $1.5M
|
155K
$668K
|
|
|
Feb 14, 2025
Q4 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-202K- 61.05% |
$920K - $1.93M
|
129K
$556K
|
|
|
Feb 14, 2025
Q4 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-2.53M- 45.53% |
$11.5M - $24.2M
|
3.03M
$13.1M
|